BeiGene
BGNE
#816
Rank
HK$190.70 B
Marketcap
HK$1,654
Share price
-0.63%
Change (1 day)
26.98%
Change (1 year)
BeiGene is a Chinese pharmaceutical company engaged in the R&D, and commercialization of molecularly-targeted, and immuno-oncology drugs for the treatment of cancer.

We have found no dividend yield history for this company